APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS - Gladman, Dafna D.; Kavanaugh, Arthur; Adebajo, Adewale O.; Gomez-Reino, Juan J.; Wollenhaupt, Juergen; Cutolo, Maurizio; Schett, Georg; Lespessailles, Eric; Mcilraith, Melissa; Hu, Chiachi; Edwards, Christopher J.; Birbara, Charles A.; et al. (2016)
EVALuna2:13313